NTI 15.5% 4.9¢ neurotech international limited

Ann: NTI Receives HREC/TGA Approval for Phase II/III ASD Trial, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 603 Posts.
    lightbulb Created with Sketch. 269
    Good luck, should do well with this price mate. This is shorter and fewer participants than I expected so should trim some cost and shorter time to market in Aus at least. Woulld be nice to know how FDA conversations are going. If this is a trial that the FDA would accept that’s a huge win! But, I’d be surprised if this is rigorous enough for FDA to approve cannabis use in Children. Happy to be proven wrong. GLTAH.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.